ARVN Q3 2020 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-74.7% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$32M-417.9% margin

Net Income

-$31M-405.7% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

+32.2%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$24M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$272M

Total Liabilities

$67M

Stockholders' Equity

$205M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$30M	-74.7%
Gross Profit	$8M	$30M	-74.7%
Operating Income	-$32M	$6M	-676.7%
Net Income	-$31M	-$18M	-74.4%